Literature DB >> 6383522

A monoclonal antibody against vimentin: characterization.

S K Pixley, Y Kobayashi, J de Vellis.   

Abstract

A monoclonal antibody was developed using rat cerebral cortex astrocytes purified in vitro as the antigenic material. Screening was done by labeling antibodies bound to cerebellum slices with fluorescent tagged secondary antibodies. The monoclonal antibody (RBA1) bound to intracellular filaments in all cells examined in culture. The coloration of tissue sections by RBA1 was identical to that described for polyclonal antibodies against the intermediate filament protein vimentin. In the brain this included binding to meninges, blood vessels, ependymal cells, choroid plexus lining cells and a subpopulation of astrocytes. The latter included Bergman glial fibers, white matter astrocytes and tanycytes. Müller cells in the retina and fibroblast-like cells in the skin, tongue and intestine were RBA1-positive. In immunoblots in which purified vimentin and desmin were run on SDS and transferred to nitrocellulose paper, RBA1 bound to vimentin but not desmin. When cultured astrocyte proteins were blotted, the antibody bound to both GFAP and vimentin, but no GFAP staining was observed in any of the tissue section staining. Purified vimentin blocked tissue and cultured cell binding of the antibody. Therefore RBA1 is considered to be an antibody specific for the intermediate filament protein vimentin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6383522     DOI: 10.1016/0165-3806(84)90096-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Characterization of cultured rat oligodendrocytes proliferating in a serum-free, chemically defined medium.

Authors:  R P Saneto; J de Vellis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

2.  Immunogold electron microscopic localization of glial fibrillary acidic protein (GFAP) in neurohypophyseal pituicytes and tanycytes of the Mongolian gerbil (Meriones unguiculatus).

Authors:  P Redecker
Journal:  Histochemistry       Date:  1989

3.  Inner retina remodeling in a mouse model of stargardt-like macular dystrophy (STGD3).

Authors:  Sharee Kuny; Frédéric Gaillard; Silvina C Mema; Paul R Freund; Kang Zhang; Ian M Macdonald; Janet R Sparrow; Yves Sauvé
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-20       Impact factor: 4.799

Review 4.  White matter astrocytes in health and disease.

Authors:  I Lundgaard; M J Osório; B T Kress; S Sanggaard; M Nedergaard
Journal:  Neuroscience       Date:  2013-11-11       Impact factor: 3.590

5.  Tuberal hypothalamic expression of the glial intermediate filaments, glial fibrillary acidic protein and vimentin across the turkey hen (Meleagris gallopavo) reproductive cycle: Further evidence for a role of glial structural plasticity in seasonal reproduction.

Authors:  Michael Q Steinman; Anthony E Valenzuela; Thomas D Siopes; James R Millam
Journal:  Gen Comp Endocrinol       Date:  2013-08-13       Impact factor: 2.822

6.  Choroid plexus tumors. An immunocytochemical study with particular reference to the coexpression of intermediate filament proteins.

Authors:  C Doglioni; P Dell'Orto; G Coggi; P Iuzzolino; L Bontempini; G Viale
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

Review 7.  Astrocyte Mitochondria in White-Matter Injury.

Authors:  Hung Nguyen; Sarah Zerimech; Selva Baltan
Journal:  Neurochem Res       Date:  2021-02-01       Impact factor: 3.996

8.  Defective Angiogenesis and Intraretinal Bleeding in Mouse Models With Disrupted Inner Retinal Lamination.

Authors:  Aaron B Simmons; Morgan M Merrill; Justin C Reed; Michael R Deans; Malia M Edwards; Peter G Fuerst
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-04       Impact factor: 4.799

9.  Functional interleukin-6 receptor-α is located in tanycytes at the base of the third ventricle.

Authors:  F Anesten; C Santos; E Gidestrand; E Schéle; V Pálsdóttir; T Swedung-Wettervik; B Meister; K Patrycja Skibicka; J-O Jansson
Journal:  J Neuroendocrinol       Date:  2017-12       Impact factor: 3.627

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.